$CHWY

CHWY Is Still Down 34% This Year: Did CHWY Stock Just Find a Bottom?

Chewy (CHWY) shares rose 6% to $21.75, despite a 34% YTD decline. The company reported 7.3% sales growth, raised full-year revenue guidance, and maintained gross margin at 30.4%. Cash decreased to $611M due to acquisitions and share buybacks. The broader pet-care sector has underperformed, with the PAWZ ETF down 10% YTD. Investors await Q3 2026 results to assess margin expansion and potential bottom.

Original reporting
Published Sep 14, 2026, 7:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CHWY Is Still Down 34% This Year: Did CHWY Stock Just Find a Bottom? — source image
Decision brief

The 30-second read

$CHWYBullishMed
01

Why it matters

The earnings beat and guidance raise provide a catalyst for a short‑term bounce, but margin flatness and cash outflow remain concerns.

02

Market read

Chewy's earnings lift offers a modest buying opportunity amid a weak pet‑care sector.

03

What to watch

Liquidity strain from the Modern Animal acquisition and share repurchases could limit near‑term financial flexibility.

Relevance 8/10Novelty 8/10Timing: today

Background

Chewy's stock has fallen 34% YTD, lagging the broader pet‑care ETF PAWZ, which is down 10% YTD.

Company-level read

Ticker impact

$CHWYBullishMedium confidence
Context

Chewy reported Q3 2026 results: sales up 7.3% YoY, met estimates, and raised full-year revenue and adjusted EBITDA margin guidance.

Expected impact

Potential upside of 5‑10% over the next week if guidance holds.

Evidence & confidence

Guidance lift offsets flat margin; market already reacted with a 6% intraday gain, indicating buying interest.

Market effects

Pet‑care sector remains weak, but Chewy's raised outlook may set a benchmark for peers.

U.S. consumer discretionary sentiment modestly improved.

Limited; primarily affects U.S. retail investors focused on pet‑care stocks.

Counterpoint

Flat gross margin and declining cash suggest the rally may be premature; downside risk if margin pressure persists.

Key entities

  • Chewy

    U.S. online pet retailer (NYSE:CHWY).

  • Modern Animal

    Pet‑care acquisition completed in the quarter.

Related articles

$CHWYHighAI 8/10

Cat People vs. Dog People: Chewy’s CEO Reveals Who’s Spending More on Their Pets Right Now, and Who’s Cutting Back

Chewy (CHWY) and Petco (WOOF) reported stronger sales in cat products and weaker dog-related sales. General Mills (GIS) saw similar trends, with cat food sales up and dog food down. Cat ownership grew faster than dog ownership, with cats costing less overall. Chewy's Q2 sales rose 7.3% YoY, and it raised full-year guidance, but its stock is down 43.72% YTD.

$CHWYMed

Chewy Puts a $50 Million Price Tag on AI Productivity

Chewy expects AI to reduce costs by $50M in fiscal 2027, up from low tens of millions this year. CEO Sumit Singh attributes savings to AI tools in customer service, pharmacy, and veterinary care. The company's AI assistant, Cai, handles 30% of chats without human agents. AI tools also improve internal operations and pharmacy processes. Chewy built the AI infrastructure in-house, giving it a competitive advantage. The savings will offset wage inflation and fund growth initiatives.

$CHWYMed

Chewy rises as Goldman Sachs maintains Buy rating on stock

Chewy Inc. shares rose 6.78% to $19.06 after Goldman Sachs maintained a Buy rating but lowered its price target to $34 from $46. The company reported Q1 earnings beat but reduced its fiscal 2026 sales outlook, prompting multiple analysts to cut price targets. Chewy's stock is down 56.34% over the past year and trades near its 52-week low.

$CHWYMedAI 8/10

Is Chewy’s (CHWY) Margin Story Losing Steam, or Is a 48% Drop the Opportunity?

Chewy (CHWY) reported Q2 2026 net sales of $3.33B, up 7.3%, and adjusted EPS of $0.36. The company raised its full-year outlook, but analysts downgraded the stock and cut price targets. CHWY stock fell 10% intraday after the results. Active customers rose 3.8% to 21.7M. Organic revenue growth slowed to 5.7%, and adjusted EBITDA margin benefited from non-recurring items. Analysts debate whether the slowdown is cyclical or structural.

$CHWYMedAI 8/10

CHWY Stock Hits Over 1-Month Low After Flat Q2 Gross Margin Overshadows Raised Outlook

Chewy Inc. (CHWY) reported Q2 net sales of $3.33B, up 7.3% YoY, meeting estimates. Adjusted EPS rose to $0.36, missing estimates by 1%. Gross margin remained unchanged at 30.4%, while adjusted EBITDA increased 23.7% to $226.7M. Chewy raised its FY26 revenue outlook but narrowed EBITDA margin guidance. CHWY stock fell 7% in morning trade, hitting a one-month low.

$CHWYHighAI 9/10

Chewy (CHWY) Is Building a Recurring Revenue Moat Through Autoship and a Vet Care Health Platform

Chewy (CHWY) reported Q2 FY2026 revenue of $3.33B, up 7.3% YoY, with Autoship sales at 84.6% of total. Active customers grew 3.8% YoY to 21.7M. Gross margin was 30.4%, and net income was $80.5M. Management raised full-year guidance, targeting $13.46B-$13.57B in net sales. Chewy Health and Vet Care showed strong growth, with 47 clinics and plans for 10-12 more.